Ataraxis AI, a frontier clinical artificial intelligence (AI) company developing AI-powered tools for oncology, today announced that its laboratory has received accreditation from the College of American Pathologists (CAP) and a clinical laboratory license from the State of California, expanding access to the Ataraxis Breast platform for clinicians and patients across the state.
CAP accreditation follows an on-site inspection by practicing pathologists covering clinical protocols, personnel qualifications, instrumentation, safety programs, and overall laboratory management. The CAP Laboratory Accreditation Program carries deeming authority from the Centers for Medicare & Medicaid Services (CMS), meaning the inspection stands in place of a CMS inspection under the Clinical Laboratory Improvement Amendments (CLIA).
Read the full article in the Caledonian Record here.